ERTAPENEM FOR INJECTION Poudre pour solution

Country: Կանադա

language: ֆրանսերեն

source: Health Canada

active_ingredient:

Ertapénem (Ertapénem sodique)

MAH:

JUNO PHARMACEUTICALS CORP.

ATC_code:

J01DH03

INN:

ERTAPENEM

dosage:

1G

pharmaceutical_form:

Poudre pour solution

composition:

Ertapénem (Ertapénem sodique) 1G

administration_route:

Intramusculaire

units_in_package:

15G/50G

prescription_type:

Prescription

therapeutic_area:

CARBAPENEMS

leaflet_short:

Numéro de groupe d'ingrédients actifs (GIA) :0149104002; AHFS:

authorization_status:

APPROUVÉ

authorization_date:

2020-05-06

SPC

PM-Ertapenem-FR
Pg. 1
(U
SpQHP SRULQMHF LRQ
3
H
GH
7DEOHGHV PDLqUHV
37,( ,(16(,*1(
(176 328 /(32)(66,211(/( /
6
17e
5(16(,*1(0(1766200 ,5(6 685/( 3528,7
,1,
7,216(786
*(
/,1,48(
2175( ,1,7,216
0,6(6(1* 5 ( (7 35e87,216
())(76 ,1e6,5 %/(6
,17(5
7,216 0e ,
0(17(86(6
3262/2*,( (7
0,1,6757,21
685 26*(
02 (¶7,21(7 3+ 502/2*,(
/,1,48(
67%,/,7e (7(175(326
*(
)250(63262/2*,48(6
20326,7,21 (7
21 ,7,211(0(17
37,( ,,
(16(,*1((176 6,(17,),48(6
5(16(,*1(0(176 3+50
(87,48(6
e78(6
/,1,48(6
3+502/2*,(
e7,//e(
0,
52%,2/2*,(
72;,
2/2*,(
5e)e5(1(6
(16(,*1((176328/( 37,(17 68 /(
e ,
(17
PM-Ertapenem-FR
Pg. 2
PM-Ertapenem-FR
Pg. 3
(U
SpQHP SRULQMHF LRQ
3
H
GH
,QIHF LRQV SHOYLHQQHV DLJXsV
FRPSULV O HQGRP RPp UL H GXSRV SDU XP O DYRU HPHQ
VHS LTXH H
OHV LQIHF LRQV J QpFRORJLTXHVSRV RSpUD RLUHV FDXVpHV SDU6 UHSRFRFF V
F LH
(VFKHULFKL
FRL
3HS RV UHSRFRFF V VSS
F HURLGHV IULLV
3RUSK URPRQ V
VFFK UR
LF
RX3UH R H
VSS
3RXU UpGXLUH O¶DSSDULWLRQ GH EDFWpULHV SKDUPDFRUpVLVWDQWHV HWSRXU
PDLQWHQLU O¶HIILFDFLWp G¶(UWDSpQHP
SRXU LQMHFWLRQ HW GHV DXWUHVPpGLFDPHQWV DQWLEDFWpULHQV (UWDSpQHPSRXU
LQMHFWLRQ GRLWrWUHXWLOLVp
XQLTXHPHQW SRXUWUDLWHUOHV LQIHFWLRQV SRXU OHVTXHOOHV LOHVW GpPRQWUp RX
IRUWHPHQW SUpVXPp TXH GHV
EDFWpULHV VHQVLEOHV HQVRQWOD FDXVH /RUVTXH GHV UHQVHLJQHPHQWV
FRQFHUQDQW OHVFXOWXUHV HW OD
VHQVLELOLWp VRQWGLVSRQLEOHV LOIDXW HQWHQLU FRPSWH SRXU FKRLVLU RX
PRGLILHUXQWUDLWHPHQW
DQWLEDFWpULHQ (Q O¶DEVHQFH GH WHOOHV GRQQpHV OHV SURILOV ORFDX[
G¶pSLGpPLRORJLH HWGH VHQVLELOLWp
SHXYHQW FRQWULEXHU DXFKRL[HPSLULTXH GXWUDLWHPHQW
2QGRLW SUpOHYHU GHVpFKDQWLOORQV DSSURSULpV
HQYXHGHVWHVWVEDFWpULRORJLTXHV SHUPHWWDQWG¶LVROHU
HWG¶LGHQWLILHU OHV PLFUR RUJDQLVPHV UHVSRQVDEOHVGHO¶LQIHFWLRQHW
GHGpWHUPLQHUOHXU VHQVLELOLWp
jO¶HUWDSpQHP2QSHXW LQVWDXUHU XQWUDLWHPHQW LQLWLDOHPSLULTXHDX PR HQ
G¶(UWDSpQHP SRXU
LQMHFWLRQ GDQVOHV FDVG¶LQIHFWLRQ EDFWpULHQQH
FRPSULVOHVLQIHFWLRQV PL[WHV HQDWWHQGDQW OHV
UpVXOWDWV GHVWHVWV EDFWpULRORJLTXHV /H WUDLWHPHQW DQWLPLFURELHQ GRLW
HQVXLWH rWUHDMXVWp VHORQOHV
UpVXOWDWVGHFHVWHVWV
3UpYHQLRQ
(UWDSpQHP
SRXULQMHFWLRQHVWLQGLT